DRUG/PRODUCT ALERT
Raptiva

Galfand Berger is investigating the complications caused by Psoriasis drug Raptiva. People who have taken or used this product have suffered from:

• Rare Brain Infection Linked to Psoriasis Drug Raptiva: PML Progressive Multifocal Leukoencephalopathy
• The PML infection leads to an irreversible decline in neurologic and brain function and death.

Symptoms of PML may include:

• Unusual weakness
• Loss of coordination
• Changes in vision
• Difficulty speaking
• Personality changes
• Other neurological changes or death.

WHAT SHOULD YOU DO?

If you have been given Raptiva and experienced any unusual side effects, contact your doctor’s office or hospital.

In order to determine whether you have a right to be compensated for your injuries, please contact Galfand Berger at 1-877-228-1528.